Cargando…

Sclerotherapy with 3% polidocanol foam: revolutionizing outpatient treatment in patients with haemorrhoidal disease

Detalles Bibliográficos
Autores principales:	Gallo, Gaetano, Ronconi, Maurizio, Trompetto, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927757/ https://www.ncbi.nlm.nih.gov/pubmed/33660166 http://dx.doi.org/10.1007/s13304-021-01008-4

Ejemplares similares

A multicentre, open-label, single-arm phase II trial of the efficacy and safety of sclerotherapy using 3% polidocanol foam to treat second-degree haemorrhoids (SCLEROFOAM)
por: Gallo, G., et al.
Publicado: (2022)

Sclerotherapy using polidocanol foam for a giant splenic cyst
por: Funakoshi, Hiraku, et al.
Publicado: (2020)

Foam Polidocanol Sclerotherapy for Low-Flow Vascular Malformations of Tongue
por: Mukul, Sailesh Kumar, et al.
Publicado: (2019)

Bilateral foam polidocanol sclerotherapy of great saphenous veins and their tributaries in synchronous procedure
por: Miranda, Luiz Antonio, et al.
Publicado: (2021)

Ethanol sclerotherapy or polidocanol sclerotherapy for symptomatic hepatic cysts
por: Wijnands, Titus FM, et al.
Publicado: (2018)

Digital Subtraction Angiography-Guided Foam Sclerotherapy with Polidocanol for Treating Superficial Venous Malformation
por: Anh, Tuan Tran, et al.
Publicado: (2021)

Polidocanol foam sclerotherapy in the treatment of hemorrhoidal disease in patients with bleeding disorders: a multicenter, prospective, cohort study
por: Salgueiro, P., et al.
Publicado: (2022)

Sclerotherapy on Demand with Polidocanol to Treat HHT Nosebleeds
por: Marcos, Sol, et al.
Publicado: (2021)

Sclerotherapy with 3% polidocanol foam for third- and fourth-degree hemorrhoids as “bridge treatment” during the COVID-19 pandemic in Italy
por: Lisi, Giorgio, et al.
Publicado: (2021)

Sclerotherapy with polidocanol microfoam in head and neck venous and lymphatic malformations
por: De Corso, Eugenio, et al.
Publicado: (2021)

Familial Disseminated Cutaneous Glomuvenous Malformation: Treatment with Polidocanol Sclerotherapy
por: Jha, Aditi, et al.
Publicado: (2016)

Successful Treatment of Acquired Vulvar Lymphangiectasia with 1% Polidocanol Sclerotherapy
por: STULL, Carolyn M., et al.
Publicado: (2021)

Editorial: Haemorrhoidal Disease: Old Solutions and Future Perspectives
por: Kuiper, Sara Z., et al.
Publicado: (2022)

3% Polidocanol Sclerotherapy for Pyogenic Granuloma: Efficacy and Safety Analysis
por: Deshpande, Ajay J, et al.
Publicado: (2022)

Therapeutic Effect of Polidocanol Sclerotherapy on Oral Vascular Malformations
por: Fukuzawa, Satoshi, et al.
Publicado: (2021)

Ultrasound-guided foam sclerotherapy of great saphenous vein with 2% polidocanol – one-year follow-up results
por: Kurnicki, Jacek, et al.
Publicado: (2016)

Effect of Hyaluronic Acid and Pluronic-F68 on the Surface Properties of Foam as a Delivery System for Polidocanol in Sclerotherapy
por: del Castillo-Santaella, Teresa, et al.
Publicado: (2020)

Influence of polidocanol ultrasound-guided foam sclerotherapy on quality of life in lower extremity chronic venous disease: initial results
por: Polimanti, Afonso César, et al.
Publicado: (2019)

Successful Endoscopic Sclerotherapy Using Polidocanol for Small Bowel Hemangioma
por: Aoyama, Taiki, et al.
Publicado: (2020)

Polidocanol sclerotherapy for multiple gastrointestinal hemangiomas: A case report
por: Yao, Huan, et al.
Publicado: (2021)

Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes
por: Pata, Francesco, et al.
Publicado: (2021)

Haemorrhoidal disease in severe portal hypertension: a combined approach with transjugular intrahepatic portosystemic shunt (TIPS) and transanal haemorrhoidal dearterialization (THD)
por: Galati, Giovanni, et al.
Publicado: (2014)

Sclerotherapy with polidocanol for treatment of aneurysmal bone cysts: Good results in 37 of 38 consecutive patients
por: Brosjö, Otte, et al.
Publicado: (2013)

Comparison between the use of 99% ethanol and 3% polidocanol in percutaneous echoguided sclerotherapy treatment of simple renal cysts
por: Dell’Atti, Lucio
Publicado: (2015)

Results of sclerotherapy and mucopexy with haemorrhoidal dearterialization in II and III degree haemorrhoids. A 4 years' single centre experience
por: Lobascio, Pierluigi, et al.
Publicado: (2023)

A combined method for the treatment of grade IV internal haemorrhoidal disease
por: Verras, Georgios-Ioannis, et al.
Publicado: (2022)

Transcervical administration of polidocanol foam prevents pregnancy in female baboons()()
por: Jensen, Jeffrey T., et al.
Publicado: (2016)

Polidocanol Sclerotherapy Combined with Transarterial Embolization Using n-Butyl Cyanoacrylate for Extracranial Arteriovenous Malformations
por: Kitagawa, Akira, et al.
Publicado: (2018)

Preliminary Results of the First 50 Patients Undergoing Sclerotherapy for II-Degree Hemorrhoidal Disease Using an Automated Device
por: Goglia, Marta, et al.
Publicado: (2022)

Efficacy and Safety of Ultrasound-Guided Percutaneous Polidocanol Sclerotherapy in Benign Cystic Thyroid Nodules: Preliminary Results
por: Gong, Xiaohua, et al.
Publicado: (2017)

A Rare Case of Aneurysmal Bone Cyst – Navicular Bone Treated by Intralesional Sclerotherapy Agent Polidocanol
por: Bansal, Kapil, et al.
Publicado: (2021)

Benefits of polidocanol endovenous microfoam (Varithena®) compared with physician-compounded foams
por: Carugo, Dario, et al.
Publicado: (2015)

Effect of Multiple Factors on Foam Stability in Foam Sclerotherapy
por: Bai, Taoping, et al.
Publicado: (2018)

Polidocanol versus hypertonic glucose for sclerotherapy treatment of reticular veins of the lower limbs: study protocol for a randomized controlled trial
por: Bertanha, Matheus, et al.
Publicado: (2014)

Guideline on haemorrhoids: AGREE-II-Criteria can be applied in different ways?
por: Jongen, Johannes, et al.
Publicado: (2023)

Comment on Pata et al. Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes. J. Clin. Med. 2022, 11, 218
por: Jongen, Johannes, et al.
Publicado: (2022)

Correction: Pata et al. Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes. J. Clin. Med. 2022, 11, 218
por: Pata, Francesco, et al.
Publicado: (2023)

Hæmorrhoids and Their Treatment
por: Stuart, W. J.
Publicado: (1938)

Treatment of Hæmorrhoids
Publicado: (1871)

Hæmorrhoids and Their Treatment
por: Chargé, A.
Publicado: (1881)

Cannot write session to /tmp/vufind_sessions/sess_qel2bmtrk48nvip7m6gtda6krn